- Home
- SLGN vs MMSI Comparison
SLGN vs MMSI Comparison
Compare SLGN & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGN
- MMSI
- Stock Information
- Founded
- SLGN 1987
- MMSI 1987
- Country
- SLGN United States
- MMSI United States
- Employees
- SLGN N/A
- MMSI N/A
- Industry
- SLGN Containers/Packaging
- MMSI Medical/Dental Instruments
- Sector
- SLGN Industrials
- MMSI Health Care
- Exchange
- SLGN Nasdaq
- MMSI Nasdaq
- Market Cap
- SLGN 5.8B
- MMSI 5.5B
- IPO Year
- SLGN 1997
- MMSI 1990
- Fundamental
- Price
- SLGN $56.57
- MMSI $83.89
- Analyst Decision
- SLGN Strong Buy
- MMSI Buy
- Analyst Count
- SLGN 9
- MMSI 9
- Target Price
- SLGN $63.78
- MMSI $109.11
- AVG Volume (30 Days)
- SLGN 663.6K
- MMSI 728.4K
- Earning Date
- SLGN 07-30-2025
- MMSI 07-30-2025
- Dividend Yield
- SLGN 1.46%
- MMSI N/A
- EPS Growth
- SLGN N/A
- MMSI 17.19
- EPS
- SLGN 2.69
- MMSI 2.04
- Revenue
- SLGN $6,004,317,000.00
- MMSI $1,388,357,000.00
- Revenue This Year
- SLGN $12.25
- MMSI $11.83
- Revenue Next Year
- SLGN $2.65
- MMSI $6.26
- P/E Ratio
- SLGN $20.43
- MMSI $41.42
- Revenue Growth
- SLGN 1.99
- MMSI 8.19
- 52 Week Low
- SLGN $44.37
- MMSI $82.62
- 52 Week High
- SLGN $58.14
- MMSI $111.45
- Technical
- Relative Strength Index (RSI)
- SLGN 57.60
- MMSI 31.76
- Support Level
- SLGN $54.89
- MMSI $82.85
- Resistance Level
- SLGN $55.67
- MMSI $94.28
- Average True Range (ATR)
- SLGN 0.89
- MMSI 2.55
- MACD
- SLGN -0.04
- MMSI -0.95
- Stochastic Oscillator
- SLGN 68.55
- MMSI 11.45
About SLGN Silgan Holdings Inc.
Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.